PBS Liposomes: Advancing Precision in Macrophage Depletion S
2026-07-02
Explore how PBS Liposomes transform macrophage depletion control by providing mechanistic clarity, robust experimental reproducibility, and strategic insights for translational researchers. Integrating recent ion channel research and best practices, this article delivers actionable guidance for leveraging APExBIO's PBS Liposomes in high-fidelity in vivo studies, while mapping new ground beyond conventional product literature.
VEGFC–VEGFR-3 Axis Disruption Attenuates NASH-Related Fibros
2026-07-02
This study demonstrates that naringin and the selective VEGFR-3 inhibitor SAR131675 protect against hepatic fibrosis in a high-fat diet-induced NASH mouse model by disrupting the VEGFC–VEGFR-3 hepatocyte–macrophage regulatory axis. The findings reveal a novel mechanism whereby VEGFC produced by hepatocytes drives macrophage recruitment and phenotypic modulation, offering new insights for anti-lymphangiogenic and anti-angiogenic therapeutic strategies in metabolic liver disease.
FLT3-ITD Mislocalisation Drives ADC Resistance in MV4-11 AML
2026-07-01
This study uncovers how the intracellular mislocalisation of the FLT3-ITD receptor in MV4-11 acute myeloid leukaemia cells impairs antibody-drug conjugate (ADC) efficacy by preventing efficient lysosomal trafficking and payload release. These findings highlight the importance of subcellular receptor localisation for optimizing ADC design and overcoming resistance in targeted AML therapies.
UK-5099 (PF-1005023) in Immunometabolism: Protocols & Troubl
2026-07-01
UK-5099 (PF-1005023) is a potent mitochondrial pyruvate carrier inhibitor uniquely suited for dissecting immune cell metabolism in standardized whole-blood assays. This guide details actionable workflows, protocol parameters, and troubleshooting advice, translating cutting-edge reference research into laboratory-ready strategies for APExBIO customers.
(Z)-4-Hydroxytamoxifen: Blueprint for Next-Gen ER Modulation
2026-06-30
(Z)-4-Hydroxytamoxifen provides translational researchers with a high-fidelity tool to dissect estrogen receptor signaling and antiestrogenic activity in breast cancer models. This article explores not only the compound’s mechanistic superiority but also strategic considerations for its deployment in contemporary translational workflows, drawing on recent insights in targeted drug delivery and cross-disciplinary innovation.
Partial BACE1 Inhibition Reduces Amyloid-β Without Synaptic
2026-06-30
Satir et al. (2020) demonstrate that partial BACE1 inhibition, resulting in less than 50% reduction of amyloid-β, does not impair synaptic transmission in cultured neurons. This finding refines the safety profile of BACE1 inhibitors such as Lanabecestat (AZD3293) and suggests that moderate inhibition may avoid synaptic side effects in Alzheimer’s disease research.
Resveratrol: SIRT1 Activator for Neuroprotection and Mitocho
2026-06-29
Resveratrol, a potent SIRT1 activator, modulates apoptosis, oxidative stress, and mitochondrial biogenesis in neuronal models. Precision control of SIRT1 pathways with resveratrol supports robust neuroprotection in prion-challenged cells. Experimental protocols require careful attention to solubility and dosing parameters.
HRP Rabbit Anti-Goat IgG (H+L) Antibody for Sensitive Immuno
2026-06-29
The HRP Rabbit Anti-Goat IgG (H+L) Antibody enables ultrasensitive detection of goat primary antibodies in complex tissue and cell models, including those studying environmental toxicants like microplastics. Its high specificity and robust HRP conjugation streamline workflows in ELISA, IHC, and Western blot, minimizing background while maximizing signal amplification. Leveraging optimized protocols and troubleshooting insights, this secondary antibody from APExBIO empowers reproducible results in cutting-edge research.
Acifran and the Evolving Frontier of Lipid Metabolism Resear
2026-06-28
This thought-leadership article explores how Acifran—a selective HM74A/GPR109A and GPR109B agonist—bridges recent cryo-EM structural insights with actionable guidance for translational researchers. By contextualizing mechanistic findings and providing strategic experimental parameters, the article aims to advance lipid metabolism research and metabolic disorder modeling beyond conventional approaches.
Nilotinib (AMN-107): Precision BCR-ABL Inhibitor for CML Res
2026-06-27
Nilotinib (AMN-107) is a selective, orally bioavailable BCR-ABL tyrosine kinase inhibitor with nanomolar potency against wild-type and mutant forms of BCR-ABL. It is widely used in chronic myeloid leukemia research for its robust kinase selectivity and favorable physicochemical properties. This article rigorously details Nilotinib's mechanism, evidence benchmarks, and integration into experimental workflows.
Purification and Kinetic Analysis of M. tuberculosis WecA
2026-06-26
This study details the over-expression, purification, and kinetic characterization of Mycobacterium tuberculosis WecA, an essential membrane enzyme for cell wall biosynthesis. By optimizing expression and solubilization strategies, the research overcomes major technical hurdles, enabling robust enzymatic studies and providing a foundation for future anti-tuberculosis drug discovery.
Targeting Fructose Metabolism: Insights for Cancer Therapy R
2026-06-26
The reference review delineates how dysregulated fructose metabolism, especially via the polyol pathway and fructose-specific transporters, underpins malignancy in aggressive cancers. By elucidating the central role of aldose reductase and GLUT5 in tumor progression, the study highlights new metabolic targets for improving therapeutic strategies and patient outcomes.
Cy5.5 NHS Ester (Non-Sulfonated): Protocols for Advanced Ima
2026-06-25
Cy5.5 NHS ester (non-sulfonated) enables highly sensitive, covalent labeling of biomolecules for in vivo and deep-tissue near-infrared fluorescence imaging. By optimizing workflow parameters and leveraging insights from recent nanoparticle studies, researchers can achieve robust, reproducible results in even the most challenging molecular and cellular biology applications.
Nile Red for Lipid Droplet Staining: Protocols and Innovatio
2026-06-25
Nile Red (Nile blue oxazone) stands out as a dual-mode fluorescent dye for precise intracellular lipid droplet staining and lipid metabolism research. This article demystifies optimized workflows, experimental pitfalls, and the latest evidence-backed strategies, empowering researchers to harness Nile Red’s full potential in lipid distribution imaging and lipid storage dynamics analysis.
Technical Guide to HyperScribe™ T7 High Yield Cy3 RNA Labeli
2026-06-24
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus addresses challenges in generating high-yield, Cy3-labeled RNA probes for research workflows such as in situ hybridization and Northern blotting. It is not intended for diagnostic, therapeutic, or clinical uses. Researchers should use this kit for applications requiring sensitive fluorescent RNA detection and avoid off-label applications.
457 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page